Supply / Manufacturing · GCC · Announced 30 Sept 2026
Dar Al Dawa → MicroSynergy Pharma
Microsynergy will manufacture and batch-release a Dar Al Dawa diabetes portfolio in JAFZA. It's a host-manufacturer model aligned with the UAE's self-sufficiency agenda.
Parties: DAR AL DAWA (Jordan) → MICROSYNERGY PHARMA (United Arab Emirates)
- Deal type
- Supply / Manufacturing
- Value
- Undisclosed
- Territory
- United Arab Emirates
- Therapeutic area
- Metabolic / Diabetes
- Asset
- A selected diabetes therapeutic portfolio from Dar Aldawa (specific molecules not disclosed)
- Announced
- 30 Sept 2026
Our analysis
Dar Aldawa and Microsynergy signed a manufacturing partnership under which Microsynergy locally manufactures and batch-releases a selected diabetes portfolio of Dar Aldawa products inside the UAE (JAFZA). DAD supplies the products, development and QA standards; Microsynergy supplies the UAE-registered manufacturing infrastructure and regulatory/batch-release capability — converting imported DAD diabetes lines into UAE-made output. Framed explicitly around the UAE's pharmaceutical self-sufficiency agenda.
The full analysis is free to read with a work email on this page.